From molecule to medicine, Cyclica embraces the complexity of the disease. With deep roots in the industry, a first-in-class platform, and an innovative decentralized partnership model, Cyclica creates medicine with greater precision for unmet patient needs. Our work spans dozens of collaborations with large pharma and biotech as well as several joint ventures. We are a passionate team of biotech and pharma professionals, biologists, chemists, and computer scientists who live and labour at the intersection of our collective expertise. Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously.

Cyclica Inc. Logo



Event details

Date: January 24 - 27, 2022

Event contact

Eyad Qudsi
Area Director
Middle East and Africa


18 in total